Publications/Links

Publications in 2022:

  1. Javed H, Singh S, Ramaraje Urs SU, Oldenburg J, Biswas A. Genetic landscape in coagulation factor XIII associated defects – Advances in coagulation and beyond. Blood Rev. 2022 Nov 2:101032. doi: 10.1016/j.blre.2022.101032 . Epub ahead of print. PMID: 36372609.
  2. Jamil, M.A.; Singh, S.; El-Maarri, O.; Oldenburg, J.; Biswas, A. Exploring Diverse Coagulation Factor XIII Subunit Expression Datasets: A Bioinformatic Analysis. Int. J. Mol. Sci. 2022, 23, 4725. https://doi.org/10.3390/ijms2309472
  3. Ghosh S, Kraus K, Biswas A, Müller J, Forin F, Singer H, Höning K, Hornung V, Watzka M, Oldenburg J, Czogalla-Nitsche KJ. GGCX variants leading to biallelic deficiency to γ-carboxylate GRP cause skin laxity in VKCFD1 patients. Hum Mutat. 2022 Jan;43(1):42-55. doi: 10.1002/humu.24300. Epub 2021 Dec 2. PMID: 34816548.

Publications in 2020-2021:

  1. Hopp MT, Alhanafi N, Paul George AA, Hamedani NS, Biswas A, Oldenburg J, Pötzsch B, Imhof D. Molecular Insights and Functional Consequences of the Interaction of Heme with Activated Protein C. Antioxid Redox Signal. 2021 Jan 1;34(1):32-48. doi: 10.1089/ars.2019.7992. Epub 2020 Aug 20. PMID: 32705892.
  2. Bäuml CA, Paul George AA, Schmitz T, Sommerfeld P, Pietsch M, PodsiadlowskiL, Steinmetzer T, Biswas A, Imhof D. Distinct 3-disulfide-bonded isomers oftridegin differentially inhibit coagulation factor XIIIa: The influence ofstructural stability on bioactivity. Eur J Med Chem. 2020 Sep 1;201:112474. doi:10.1016/j.ejmech.2020.112474. Epub 2020 May 23. PMID: 32698061.
  3. Bhakuni T, Sharma A, Biswas A, Bano S, Mahapatra M, Saxena R, Jairajpuri MA. Identification and characterization of a novel variant in C-terminal region ofAntithrombin (Ala427Thr) associated with type II AT deficiency leading topolymer formation. J Thromb Thrombolysis. 2020 Oct;50(3):678-685. doi:10.1007/s11239-020-02048-0. PMID: 32020514.
  4. Ramezanpour N, Zaker F, Biswas A, Dorgalaleh A. Inhibitor in CongenitalFactor VII Deficiency; a Rare but Serious Therapeutic Challenge-A SystematicLiterature Review. J Clin Med. 2021 Jan 8;10(2):211. doi: 10.3390/jcm10020211.PMID: 33435610; PMCID: PMC7827513.
  5. Akhter MS, Hamali HA, Mobarki AA, Rashid H, Oldenburg J, Biswas A. SARS-CoV-2 Infection: Modulator of Pulmonary Embolism Paradigm. J Clin Med. 2021 Mar4;10(5):1064. doi: 10.3390/jcm10051064. PMID: 33806540; PMCID: PMC7961449.
  6. Schmitz T, Paul George AA, Nubbemeyer B, Bäuml CA, Steinmetzer T, Ohlenschläger O, Biswas A, Imhof D. NMR-Based Structural Characterization of a Two-Disulfide-Bonded Analogue of the FXIIIa Inhibitor Tridegin: New Insights into Structure-Activity Relationships. Int J Mol Sci. 2021 Jan 17;22(2):880. doi: 10.3390/ijms22020880. PMID: 33477282; PMCID: PMC7830451.
  7. Yadegari H, Biswas A, Ahmed S, Naz A, Oldenburg J. von Willebrand factor propeptide missense variants affect anterograde transport to Golgi resulting in ER retention. Hum Mutat. 2021 Jun;42(6):731-744. doi: 10.1002/humu.24204. Epub 2021 May 3. PMID: 33942438.
  8. Rad F, Dabbagh A, Dorgalaleh A, Biswas A. The Relationship between Inflammatory Cytokines and Coagulopathy in Patients with COVID-19. J Clin Med. 2021 May 9;10(9):2020. doi: 10.3390/jcm10092020. PMID: 34065057; PMCID: PMC8125898.
  9. Ghosh S, Kraus K, Biswas A, Müller J, Buhl AL, Forin F, Singer H, Höning K, Hornung V, Watzka M, Czogalla-Nitsche KJ, Oldenburg J. GGCX mutations show different responses to vitamin K thereby determining the severity of the. hemorrhagic phenotype in VKCFD1 patients. J Thromb Haemost. 2021 Jun;19(6):1412-1424. doi: 10.1111/jth.15238. Epub 2021 May 4. PMID: 33590680.
  10. Hamedani NS, Biswas A, Rudan O, Tönges R, Meyring C, Tolle F, Mayer G, Oldenburg J, Müller J, Pötzsch B. Functional and Structural Characterization of Nucleic Acid Ligands That Bind to Activated Coagulation Factor XIII. J Clin Med. 2021 Feb 10;10(4):677. doi: 10.3390/jcm10040677. PMID: 33578732; PMCID: PMC7916480.

Publications in 2019-2020:

  1. Hopp MT, Alhanafi N, Paul George AA, Hamedani NS, Biswas A, Oldenburg J, Pötzsch B, Imhof D. Molecular Insights and Functional Consequences of the Interaction of Heme with Activated Protein C. Antioxid Redox Signal. 2020 Aug 20.
  2. Bäuml CA, Paul George AA, Schmitz T, Sommerfeld P, Pietsch M, Podsiadlowski L, Steinmetzer T, Biswas A, Imhof D. Distinct 3-disulfide-bonded isomers of tridegin differentially inhibit coagulation factor XIIIa: The influence of structural stability on bioactivity. Eur J Med Chem. 2020 Sep 1;201:112474.
  3. Bhakuni T, Sharma A, Biswas A, Bano S, Mahapatra M, Saxena R, Jairajpuri MA. Identification and characterization of a novel variant in C-terminal region of Antithrombin (Ala427Thr) associated with type II AT deficiency leading to polymer formation. J Thromb Thrombolysis. 2020 Oct;50(3):678-685.
  4. Singh S, Nazabal A, Kaniyappan S, Pellequer JL, Wolberg AS, Imhof D, Oldenburg J, Biswas A. The Plasma Factor XIII Heterotetrameric Complex Structure: Unexpected Unequal Pairing within a Symmetric Complex. Biomolecules. 2019 Nov 21;9(12):765.
  5. Sharma A, Biswas A, Liu H, Sen S, Paruchuri A, Katsonis P, Lichtarge O, Chand Dakal T, Maulik U, Gromiha MM, Bandyopadhyay S, Ludwig M, Holz FG, Loeffler KU, Herwig-Carl MC. Mutational Landscape of the BAP1 Locus Reveals an Intrinsic Control to Regulate the miRNA Network and the Binding of Protein Complexes in Uveal Melanoma. Cancers (Basel). 2019 Oct 19;11(10):1600.
  6. Singh S, Dodt J, Volkers P, Hethershaw E, Philippou H, Ivaskevicius V, Imhof D, Oldenburg J, Biswas A. Structure functional insights into calcium binding during the activation of coagulation factor XIII A. Sci Rep. 2019 Aug 5;9(1):11324.
  7. Singh S, Akhter MS, Dodt J, Volkers P, Reuter A, Reinhart C, Krettler C, Oldenburg J, Biswas A. Identification of Potential Novel Interacting Partners for Coagulation Factor XIII B (FXIII-B) Subunit, a Protein Associated with a Rare Bleeding Disorder. Int J Mol Sci. 2019 May 31;20(11):2682.
  8. Singh S, Akhter MS, Dodt J, Sharma A, Kaniyappan S, Yadegari H, Ivaskevicius V, Oldenburg J, Biswas A. Disruption of Structural Disulfides of Coagulation FXIII-B Subunit; Functional Implications for a Rare Bleeding Disorder. Int J Mol Sci. 2019 Apr 22;20(8):1956.
  9. Akhter MS, Singh S, Yadegari H, Ivaskevicius V, Oldenburg J, Biswas A. Exploring the structural similarity yet functional distinction between coagulation factor XIII-B and complement factor H sushi domains. J Thromb Thrombolysis. 2019 Jul;48(1):95-102.
  10. Ahmed S, Yadegari H, Naz A, Biswas A, Budde U, Saqlain N, Amanat S, Tariq S, Raziq F, Masood S, Pavlova A, Shamsi TS, Oldenburg J. Characterization of the mutation spectrum in a Pakistani cohort of type 3 von Willebrand disease. Haemophilia. 2019 Nov;25(6):1035-1044.
  11. Bäuml CA, Schmitz T, Paul George AA, Sudarsanam M, Hardes K, Steinmetzer T, Holle LA, Wolberg AS, Pötzsch B, Oldenburg J, Biswas A, Imhof D. Coagulation Factor XIIIa Inhibitor Tridegin: On the Role of Disulfide Bonds for Folding, Stability, and Function. J Med Chem. 2019 Apr 11;62(7):3513-3523.
  12. Melzer C, Sharma A, Peters S, Aretz S, Biswas A, Holz FG, Loeffler KU, Herwig-Carl MC. Basal cell carcinomas developing independently from BAP1-tumor predisposition syndrome in a patient with bilateral uveal melanoma: Diagnostic challenges to identify patients with BAP1-TPDS. Genes Chromosomes Cancer. 2019 Jun;58(6):357-364.

Complete list of publications of PD Dr. rer. nat. Arijit Biswas

Complete list of publications of Prof J. Oldenburg